Implementation for pharmaceuticals (AMNOG: German Law for Reforming the Market for Pharmaceuticals) and medical devices.
From a payer’s perspective in the various lifecycle stages of a product.
Key questions being answered in a Strategic Payer Plan.
Development of market access & pricing as well as global clinical development strategies from a payer's perspective in the various lifecycle stages of a product...
MArS in conjunction with Dove Press launched the German Journal of ClinicoEconomics. More: germanjournal-clinicoeconomics.de
THE German-speaking market access experts - Austria, Germany, Switzerland
MArS focuses on the four topics strategy, Austrian, German and Swiss market access, pricing and health economic strategy & implementation.